United States

Growing the Pipeline, Growing the Bottom Line - Shifts in Pharmaceutical R&D Innovation

Jul 04, 2014
From the Healthcare & Life Sciences Institute

This report, titled Growing the pipeline, growing the bottom line: Shifts in pharmaceutical R&D innovation, looks at the great research challenge through the eyes of senior R&D executives from some of the world’s leading pharma companies.

Their responses suggest:

  • Pharmaceutical R&D innovation is on the rise, with 70 percent of respondents believing their companies are enjoying a resurgence in research productivity
  • Organizational barriers to R&D innovation persist: 72 percent of respondents claim that excessive administrative work prevents scientists from devoting time to research
  • Pharmaceutical R&D outsourcing and collaboration is set to continue, with an increasing proportion of research budgets spent externally